Eastern Virginia Medical School

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Eastern Virginia Medical School sits in the top decile of US sponsors by registered trial count (#467 of 15,742 sponsors by registered trial count).

36 total trials 6 currently recruiting 24 completed top decile by trial count

Eastern Virginia Medical School: 36 sponsored US clinical trials, 6 recruiting.

Eastern Virginia Medical School sponsors 36 registered US clinical trials on ClinicalTrials.gov, 6 of them currently recruiting, and 24 completed. 9 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Nerve Pain, with 1 trials.

Top-decile sponsor footprint

Eastern Virginia Medical School ranks in the top decile of sponsors by registered trial count (#467 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 46/100

24 of 29 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

36 total, page 1 of 1

RECRUITING Phase 4

Once-Daily vs Twice-Daily Insulin Glargine in Pregestational Diabetes Management

NCT07224893

RECRUITING Phase 4

Lactated Ringer's and Dextrose 5% vs Only Lactated Ringer's in Labor

NCT07124130

RECRUITING Phase 4

Oxytocin/Foley vs. Oxytocin for Induction in Patients With PPROM

NCT07119398

RECRUITING NA

Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes

NCT06867861

RECRUITING

Ultrasound Findings in Diabetic Pregnancies

NCT06407388

RECRUITING Phase 2

Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease

NCT04436081

NOT YET RECRUITING NA

Glucose Control in Type 2 Diabetes in Pregnancy

NCT07250698

COMPLETED Phase 1

Rectal Insert TAF/EVG Pre-Exposure Prophylaxis (RITE PrEP) Study

NCT06274398

COMPLETED Phase 1

Safety and PK Multi-dose Study of TAF/EVG Vaginal Insert

NCT06087913

COMPLETED NA

VR for Lac Repairs in Peds Emergency Department

NCT06516003

COMPLETED NA

Effect of CPAP on Fetal pH at Scheduled C-section in Morbidly Obese Women

NCT04993651

TERMINATED NA

Effect of Sterile Versus Clean Gloves Intrapartum and Postpartum Infections at Term

NCT05603624

COMPLETED Early Phase 1

Project ADHERE: Clinical Proof-of-Concept of a Tenofovir (TFV) Aptamer-Based Biosensor

NCT04870671

COMPLETED Phase 4

Impact of Contraceptives on Cervico-Vaginal Mucosa

NCT04814927

COMPLETED

Ultrasound Assessment of DILAPAN-S

NCT04529837

TERMINATED NA

Effects of Nicotine Salt Aerosol on Cigarette Smokers

NCT03974152

TERMINATED NA

Use of Electroconvulsive Therapy to Treat Self-Injurious Behavior in Adults With Autism Spectrum Disorders

NCT03980366

COMPLETED Phase 1

Safety and Tolerability Study of Antimicrobial TheraGauze for Skin Abscess

NCT02334384

COMPLETED Phase 4

Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects

NCT02682901

COMPLETED Phase 3

Muscarinic Receptor Antagonists as a Therapy for Diabetic Neuropathy

NCT03050827

COMPLETED

Urinary Leukotriene E4 Levels in Children With Obstructive Sleep Apnea

NCT02205346

COMPLETED

Effect of Copper Impregnated Textiles on Healthcare Associated Infections and Antibiotic Use

NCT02351895

COMPLETED NA

Safety Study of Quickclot for Bleeding Control After Adenotonsillectomy

NCT01863563

COMPLETED Phase 2

Intradermal Versus Intramuscular Polio Vaccine Booster in HIV-Infected Subjects

NCT01686503

COMPLETED NA

Turbinate Cauterization in Pediatric Patients With Nasal Obstruction

NCT01695967

COMPLETED NA

Laryngeal Mask Airway in Pediatric Adenotonsillectomy

NCT01695980

COMPLETED Phase 2

Vaginal Progesterone Supplementation in Women With PCOS Undergoing Ovulation Induction With Letrozole

NCT03440359

TERMINATED Phase 1

Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus

NCT01603121

TERMINATED Phase 4

Enteral Nutrition and Glycemic Variability Neurological Intensive Care Unit Study

NCT01463878

COMPLETED

BRIPPED Scan for Evaluation of Emergency Department (ED) Patients With Shortness of Breath

NCT01662843

COMPLETED NA

Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea

NCT01539278

COMPLETED Phase 3

The Effect of Pregabalin on Pain Related to Walking in Patients With Diabetic Peripheral Neuropathy

NCT02927951

COMPLETED Phase 4

Lovaza® and Microvascular Function in Type 2 Diabetes

NCT00931879

COMPLETED NA

Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants

NCT01523769

COMPLETED

Role of Prostaglandins on Niacin-Induced Flushing

NCT00930839

COMPLETED NA

A Study of Attitudes About the Risk of Developing Type 2 Diabetes

NCT00323349

What is open in the Eastern Virginia Medical School pipeline

6 recruiting of 36 indexed (17% open); 24 completed (67%).

Phase mix: 9 late (III/IV) vs 8 early (I/II) (balanced across stages).

Top condition: Nerve Pain (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Eastern Virginia Medical School: open-pipeline peers nationwide

Peers matched on 36 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

Eastern Virginia Medical School sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 010203040 0%5%10%15%20% Total trials Recruiting share Eastern Virginia Medical SchoolAcorda TherapeuticsBaystate Medical CenterEnanta PharmaceuticalsMacroGenicsAdageneAgendiaAkamis BioAngiodynamics
Eastern Virginia Medical School sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Eastern Virginia Medical School sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 36 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

What to do with this Eastern Virginia Medical School page

36 registered trials is a research-attention snapshot, not an endorsement of Eastern Virginia Medical School or any single study.

  • 6 of Eastern Virginia Medical School's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Nerve Pain is the condition Eastern Virginia Medical School studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Nerve Pain trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Eastern Virginia Medical School pipeline card: 36 registered trials from official public datasets.Report a data error.